在肝癌中以小分子为基础的向治疗
Yue Ming1, Yanqiu Gong2, Xuewen Fu3
1Laboratory of Molecular Oncology, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610064, China.
概括
小分子向疗法为晚期肝癌患者提供了新的希望. 研究探索已批准的,临床前和研究中的治疗方法,旨在克服耐药性并提高生存率.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 肝癌是全球主要的恶性瘤,通常在晚期被诊断出来.
- 目前的临床指南建议小分子向疗法,如索拉费尼布和伦瓦提尼布作为一线治疗.
- 尽管取得了进展,但现有的疗法对许多肝癌患者提供了有限的临床益处.
研究的目的:
- 总结目前和新兴的小分子向性肝癌治疗方法.
- 审查这些疗法的发现,临床试验,机制和耐药性模式.
- 分析目前的情况,并提出肝癌治疗的未来方向.
主要方法:
- 对已批准的,临床前和试验中的小分子向疗法的文献综述.
- 对临床试验数据,分子机制和耐药性的分析.
- 讨论组合疗法和未来的研究途径.
主要成果:
- 关键的小分子向疗法 (sorafenib,lenvatinib,regorafenib,cabozantinib) 已成为一线和二线治疗.
- 目前正在进行的研究正在研究新药和组合策略,以提高疗效.
- 药物耐药性的机制正在被阐明,指导克服策略的发展.
结论:
- 小分子向疗法代表了肝癌管理的关键方法.
- 解决药物耐药性和探索新型治疗组合对于改善患者的治疗结果至关重要.
- 需要进一步的研究来确定更有效的治疗方法和肝癌的新技术.
更多相关视频
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
341
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.1K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K